Men with metastatic castration-resistant prostate cancer and symptomatic bone metastases had longer survival times when they received radium-223 as first-line therapy compared with those who received ...
QUINCY, Mass., Jan. 27, 2025 /PRNewswire/ -- The Prostate Health Education Network (PHEN), an organization with a mission to eliminate the African American prostate cancer disparity, announced that ...
Only 11% of patients required BPH drugs at 5 years post treatment 90% freedom from secondary procedures though 5 years MINNEAPOLIS, April 26, 2011 (GLOBE NEWSWIRE) -- Urologix®, Inc. (Nasdaq:ULGX), ...
Peer-reviewed findings demonstrate high disease control and quality-of-life preservation, supporting shift toward focal therapy in prostate treatment “The publication of the PRESERVE study in European ...
This Case Study describes a 60-year-old woman who presented with an enlarging subcutaneous lesion on her right flank, 6 months after having undergone treatment for transitional cell carcinoma (TCC) of ...
2025 SEP 19 (NewsRx) -- By a News Reporter-Staff News Editor at Insurance Daily News-- Investigators discuss new findings in Managed Care. According to news reporting originating in Chicago, Illinois, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results